Structure Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 17.98 million compared to USD 13.08 million a year ago. Basic loss per share from continuing operations was USD 0.75 compared to USD 4.32 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.84 USD | -1.52% |
|
+11.55% | +7.85% |
Jun. 27 | Structure Therapeutics Inc. Appoints Ted W. Love as to the Audit Committee | CI |
Jun. 07 | Structure Therapeutics Closes $547.4 Million Offering | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.85% | 2.08B | |
+20.13% | 127B | |
+24.29% | 117B | |
+25.44% | 27.67B | |
-18.14% | 20.33B | |
-15.17% | 16.79B | |
-15.57% | 15.63B | |
+12.86% | 14.84B | |
-47.10% | 14.65B | |
+56.04% | 14.43B |
- Stock Market
- Equities
- GPCR Stock
- News Structure Therapeutics Inc.
- Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023